Literature DB >> 27451027

New hybrid magnetic nanoparticles based on chitosan-maltose derivative for antitumor drug delivery.

Liana Alupei1, Catalina Anisoara Peptu1, Andreea-Maria Lungan2, Jacques Desbrieres3, Ovidiu Chiscan4, Sadia Radji3, Marcel Popa5.   

Abstract

The aim of the present study is to obtain, for the first time, polymer magnetic nanoparticles based on the chitosan-maltose derivative and magnetite. By chemically modifying the chitosan, its solubility in aqueous media was improved, which in turn facilitates the nanoparticles' preparation. Resulting polymers exhibit enhanced hydrophilia, which is an important factor in increasing the retention time of nanoparticles in the blood flow. The preparation of nanoparticles relied on the double crosslinking technique (ionic and covalent) in reverse emulsion which ensures the mechanical stability of the polymer carrier. The characterization of both the chitosan derivative and nanoparticles was accomplished by Fourier Transform Infrared Spectroscopy, Nuclear Magnetic Resonance Spectroscopy, Scanning Electron Microscopy, Transmission Electron Microscopy, Atomic Force Microscopy, Vibrating Sample Magnetometry, and Thermogravimetric Analysis. The evaluation of morphological, dimensional, structural, and magnetical properties, as well as thermal stability and swelling behavior of nanoparticles was made from the point of view of the polymer/magnetite ratio. The study of 5-Fluorouracil loading and release kinetics as well as evaluating the cytotoxicity and hemocompatibility of nanoparticles justify their adequate behavior in their potential use as devices for targeted transport of antitumor drugs.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-Fluorouracil; Chitosan; Magnetite; Maltose; Nanoparticle

Mesh:

Substances:

Year:  2016        PMID: 27451027     DOI: 10.1016/j.ijbiomac.2016.07.058

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

1.  A chemiluminescence assay for determination of lysozyme based on the use of magnetic alginate-aptamer composition and hemin@HKUST-1.

Authors:  Yanna Lin; Yuanling Sun; Yuxue Dai; Xiaodong Zhu; Hao Liu; Rui Han; Dandan Gao; Chuannan Luo; Xueying Wang
Journal:  Mikrochim Acta       Date:  2020-04-20       Impact factor: 5.833

2.  pH-Responsive Charge-Conversional and Hemolytic Activities of Magnetic Nanocomposite Particles for Cell-Targeted Hyperthermia.

Authors:  Md Abdur Rahman; Yoshimasa Matsumura; Shigekazu Yano; Bungo Ochiai
Journal:  ACS Omega       Date:  2018-01-25

Review 3.  The Role of Magnetic Nanoparticles in Cancer Nanotheranostics.

Authors:  Maria Ferreira; João Sousa; Alberto Pais; Carla Vitorino
Journal:  Materials (Basel)       Date:  2020-01-07       Impact factor: 3.623

4.  Chitosan Grafted Poly (Ethylene Glycol) Methyl Ether Acrylate Particulate Hydrogels for Drug Delivery Applications.

Authors:  Corina-Lenuța Logigan; Christelle Delaite; Crina-Elena Tiron; Cristian Peptu; Marcel Popa; Cătălina Anișoara Peptu
Journal:  Gels       Date:  2022-08-09

Review 5.  Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity.

Authors:  Laís Salomão Arias; Juliano Pelim Pessan; Ana Paula Miranda Vieira; Taynara Maria Toito de Lima; Alberto Carlos Botazzo Delbem; Douglas Roberto Monteiro
Journal:  Antibiotics (Basel)       Date:  2018-06-09

6.  Antitumoral Drug: Loaded Hybrid Nanocapsules Based on Chitosan with Potential Effects in Breast Cancer Therapy.

Authors:  Kheira Zanoune Dellali; Delia Mihaela Rata; Marcel Popa; M'hamed Djennad; Abdallah Ouagued; Daniela Gherghel
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

Review 7.  Glycosylated-Chitosan Derivatives: A Systematic Review.

Authors:  Pasquale Sacco; Michela Cok; Francesca Scognamiglio; Chiara Pizzolitto; Federica Vecchies; Andrea Marfoglia; Eleonora Marsich; Ivan Donati
Journal:  Molecules       Date:  2020-03-27       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.